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Nodular disease of the thyroid is extremely common.  As many as 3 – 7% of asymptomatic 
individuals may have clinically palpable nodules, and up to 50% will have nodularity detected on 
ultrasound. Thyroid cancer is relatively rare, with an incidence of 1 – 2 /100 000. Unfortunately, 
differentiating benign from malignant thyroid disease remains a challenge.  
 
Ultrasound and cytological assessment are essential parts of the investigation of thyroid nodules, 
yet in most cases both have insufficient accuracy to allow a definitive diagnosis.  
 
As nodular disease of the thyroid is very common, cancer rare and the diagnosis difficult to 
confirm, clinical decision making can be difficult. Yet having a confident pre operative diagnosis 
of thyroid cancer greatly facilitates surgical intervention and is cost effective. Identifying the 
potential areas for improvement in the various parts of our diagnostic algorithm may streamline 


















 assess the accuracy of pre operative diagnosis of thyroid cancer in a single centre
Secondary Aims: 
 evaluate the impact of preoperative diagnosis on surgical interventions for thyroid
carcinoma
 develop locally applicable guidelines for patients with nodular disease of the thyroid
Methods 
This is a retrospective review of all patients diagnosed with thyroid carcinoma evaluated or 
managed at Groote Schuur from 2004 to 2010. Oncology, pathology and surgical records will be 
used to identify all patients treated during this time. 
Data will be captured against an anonymous code and entered on a standardized proforma. 
Each component of the preoperative diagnostic process will be evaluated against the final 
histological report for its positive and negative predictive value. The diagnostic accuracy for 
different histological subtypes of thyroid cancer will also be evaluated. 
Anticipated Outcomes
This study will provide an audit of the diagnostic accuracy of thyroid carcinoma in our unit and 
guide the development of appropriate, workable guidelines for management of nodular disease of 
the thyroid in our region. This may have beneficial clinical impact and allow for better use of 
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Pre-Operative Diagnosis of Thyroid Cancer: 




The pre-operative diagnosis of thyroid cancer remains a complex problem for general surgeons and 
endocrinologists. The high prevalence of thyroid nodules in the general population and the relative 
rarity of thyroid carcinoma make the pre- operative diagnosis of malignancy critical to preventing 
hundreds of unnecessary diagnostic procedures. Unfortunately no single diagnostic modality can 
confidently rule out thyroid malignancy. The increased use of high resolution imaging in modern 
medicine and the consequent flood of the incidental thyroid nodules make the development of 
accurate thyroid diagnostics an urgent public health concern.  
 
This literature review will examine the current status of the predictive accuracy of clinical 
assessment, ultrasound and fine-needle biopsy in making the diagnosis of thyroid cancer.   
 
 
Section 1: Background 
 
1.1. Histopathology of thyroid nodules 
A thyroid nodule is a discrete lesion within the parenchyma which can be detected either by 
palpation or ultrasound
 1
. Thyroid nodules may be neoplastic or non- neoplastic with neoplastic 
nodules either benign or malignant (Table 1). 
 
Non neoplastic lesions include simple cysts, haemorrhagic cysts, colloid nodules, hyperplastic 
nodules and palpable abnormalities related to underlying glandular pathology such as Hashimotos’ 
thyroiditis. Colloid nodules are areas of hyperplasia within the gland which contain enlarged 
macrofollicles filled with colloid and lined by flattened thyroid epithelial cells 
2
.   
 
Benign neoplasms are most commonly follicular adenomas or Hurtle cell adenomas. Adenomas 
are characterised by a thick, fibrous capsule, have uniform cells of ordered architecture with few 















eosinophilic due to the abundance of cytoplasmic mitochondria. Adenomas differ from 
hyperplastic nodules in that they are of monoclonal cellular origin and have a thick, well defined 
capsule. Differentiating follicular adenomas from carcinomas is impossible on cytology and can be 




Well differentiated carcinomas (>90%) are papillary, follicular carcinomas and Hurtle cell 
carcinomas. Anaplastic and medullary carcinomas have a completely different clinical course and 
treatment. Lymphoma and distant metastases may present as a primary tumour in the thyroid.  
 
Table 1: Differential Diagnosis of Thyroid Nodules 
Benign – Non Neoplastic (80%) Malignant – Neoplastic (5 – 10%) 
- Simple cyst - Papillary carcinoma 
- Colloid Nodule   - Follicular carcinoma 
- Hyperpastic nodule in MNG - Medullary carcinoma 
- Hashimoto’s Thyroiditis - Anaplastic carcinoma 
  
Benign – Neoplastic (10 -15%) Rare Tumours 
- Follicular adenoma - Primary lymphoma 
- Hurtle cell adenoma - Sarcoma 
- Embryonal adenoma - Metastases 
 
 
1.2. Aetiology – Thyroid Nodules  
The aetiology of thyroid nodules is believed to be multifactorial: age, iodine deficiency, sex and 




Iodine deficiency has long been established as a causative factor in the development of 
multinodular goitre 
5
. Iodine deficiency is caused by naturally occurring deficiencies within the 
soil in endemic areas typically in mountainous regions of the world or areas which have lost top 
soil cover. Endemic goitre areas occur on every continent. African countries affected are Morocco, 
Chad, Tunisia, Mozambique, Lesotho and in Europe parts of Italy, Spain, Germany, Poland, 















has decreased endemic goitre with relative success. South Africa is currently defined by the WHO 




Female preponderance is consistently noted in all studies on thyroid nodular disease with a 
female-male ratio of between 5:1 and 10:1 
7
. The reason for this is not clear but the presence of 




Irradiation of the head and neck for cancer or even for benign disease was relatively common in 
the first part of the 20
th
 century. There is clear association between irradiation and the development 
of benign and malignant thyroid nodules 
9
. The development of nodules may also be affected by 




  showsin 
1.3. Prevalence of Thyroid nodules – Scale of the Problem 
Thyroid nodules are extremely common. The first population based report on the incidence of 
thyroid nodules in the normal population comes from the small town of Framingham, 21 km from 
Boston, Massachusetts in 1948 
11
. This town was selected for an epidemiology study on CVS 
disease and included 6600 participants. Palpation of the thyroid gland was part of the clinical 
examination and results showed that 4.2% of the normal, asymptomatic population had palpable 
thyroid nodules (6.4% in females, 1.5% in males). The next population study commonly quoted 
was in Whickham, UK where the prevalence of all types of thyroid disease was assessed. Closely 
reproducing the results of the Massachusetts study, 5.3% women and 0.8% men in the normal 
population had palpable thyroid nodules 
12
. Later studies have confirmed the rate of palpable 
nodules to range from 3 – 7% 
13
 with an average of 5% depending on the iodine deficiency history 
of the region.  
 
The use of high resolution ultrasound has caused an explosion in the detection of thyroid nodules. 
The presence of incidental thyroid nodules on ultrasound varies from study to study, ranging from 
17 – 48%. Improvements in imaging has revealed that up to 48% of patients who were thought to 
have solitary nodules on clinical examination, in fact have multiple nodules on ultrasound 
14
.  
Autopsy studies are the gold standard for assessing the true prevalence of thyroid nodules. The 
first recorded autopsy study was conducted at the Mayo clinic in 1955 by Mortenssen and 
colleagues. A total of 821 thyroid glands in patients with no clinical thyroid disease were 
evaluated. 50.5% had thyroid nodules of which 4.2% were malignant 
15
. Subsequent autopsy 
















Thus thyroid nodules are present in at least 50% of the adult population, approximately 5% of 
asymptomatic individuals will have a palpable nodule and the percentage detected with high 
resolution ultrasound continues to rise.  Without rational criteria regarding fine-needle aspiration 
biopsy (FNA), ultrasound and surgery, there is a risk of being overwhelmed by this avalanche of 
thyroid nodules. 
In sharp contrast to the prevalence of thyroid nodules, thyroid cancer is a rare disease. The annual 
incidence is 1-2/100 000 though this accounts for 90% of the total malignancies of the endocrine 
system 
16
. Most thyroid cancers are well differentiated (90%) with a relatively good prognosis. In
fact autopsy studies show that between 5 and 13% of thyroid glands harbour thyroid cancer 
clinically undetected during the patients’ lifetime 
17
.
The world-wide incidence of thyroid cancer is rising and has almost doubled in the last 30 years 
but mortality from thyroid cancer has remained unchanged. This may be because small papillary
carcinomas of less than 2cm constitute 87% of this rise
18
. In fact the increase may only be due to 
improvements in the detection of sub clinical and probably insignificant small cancers. These
increasing numbers of patients are being subjected to surgery, long term follow up and the 
psychological burden of a cancer diagnosis. Thus John Cronan in a recent editorial appeals for the 
research focus to move from the diagnosis of small, impalpable thyroid nodules and shift to




Section 2: General Predictors of Risk: 
2.1.History 
History taking should include a history of head and neck irradiation and a family history of 
papillary or medullary cancer. Other rare familial syndromes such as MEN 2, FAP and Cowden’s 
disease are also risk factors as is the presence of thyroid nodules in childhood 
19
.
Male sex as a risk factor for thyroid malignancy is variably reported in the literature 
20
.  The vast
majority of thyroid nodules are in women and historically nodules in men were believed to have a 















many recent studies do not support the finding 
21,22,23
. Some even demonstrate a higher incidence 
in women than men 
24
. Where a difference is noted in recent research it seems to be relatively 
small for example 11.5% vs 7% 
25
. The small number of men with thyroid nodules and therefore 
proportionally small number with thyroid cancer may be the cause of these discrepancies.   
 
The duration of the presence of the thyroid nodule as well as its pattern of growth is important. 
Most thyroid malignancies will grow progressively over time. A sudden rapid increase in size 
associated with pain is usually related to haemorrhage into a cyst 
1
. Unfortunately, benign solid 
nodules also increase in size with 90% increasing by over 15% over 5 years 
26
. Critical questions 
on history also include asking about voice change and worsening compressive symptoms.  
 
2.2. Clinical Examination 
Clinical examination should include general examination, palpation of the nodule, the entire gland 
as well as the anterior and lateral nodal compartments for lymphadenopathy. Though palpation is 
not very sensitive, a hard fixed nodule with obvious adenopathy increases the suspicion of 
malignancy. Most patients with well differentiated thyroid carcinomas do not present with any 
significant risk factors on history or worrying signs on clinical examination.   
 
2.3. Solitary Nodule vs Multinodular Goitre 
Nodular goitres are clinically recognisable enlargements of the thyroid gland resulting from 
structural or functional changes. Until recently, it has been convention to view solitary nodules as 
having a significantly higher risk of malignancy than nodules in a multinodular goitre. Recent data, 
however, does not support this assessment. It is also important to note that palpation alone cannot 
accurately distinguish a solitary nodule from a multinodular goitre.  
 
In 2006 Frates et al conducted a retrospective study 1985 patients to look at the prevalence of 
malignancy in multinodular goitres 
27
. The study included 1181 patients with a solitary nodule and 
804 with multiple nodules. The rate of malignancy was 14.8% in patients who had a solitary 
nodule and 14.9% in patients with a multiple nodules. Solitary nodules had a higher likelihood of 
malignancy than each nodule in a multinodular goitre but the overall risk per patient was the same. 
In their study, up to four nodules greater than 10mm in size and with suspicious US findings were 
















Similar results were found in retrospective studies by Gandolphi et al 
28
, and Tollin et al 
29
. In a 
large prospective study done by Papinni et al in Italy, the rate of malignancy was 6.3% for solitary 
nodules and 9.2% of patients with multinodular goitre. This was not a statistically significant 
difference. This study also demonstrated that size criteria to determine which nodule to biopsy 
detected only 5.8% malignancies whereas using suspicious ultrasound criteria increased the 
diagnostic rate to 21.7% 
30
. In the work done by Cappelli et al 
23
, malignancy was slightly higher in 
the MNG group than in the solitary nodule group.  
 
Multinodularity can therefore no longer be viewed as decreasing the risk of cancer. The practise of 
assessing the largest nodule or dominant nodule in a multinodular goitre is not only inaccurate but 
probably also increases the number of unnecessary procedures performed. Nodules in MNG should 
be assessed according to the ultrasound characteristics and identified for FNA on the basis of 
suspicious features and not size alone. More than one nodule may need to be biopsied if these 
criteria are applied.  
 
2.4. Size 
The size of thyroid nodules has long been perceived as an important factor in their risk of 
malignancy.  However recent studies on small thyroid nodules show that the size of the nodule has 
no bearing on the rate of malignancy. In the large series published by Papini et al there was no 
difference in cancer rates within nodules 8 – 10mm and 11 – 15 mm 
30
. Similarly, in a long term 
study from Boston, Yassa et al found no difference in cancer rates in nodules between 1cm and 
greater than 3cm 
31
. Similar results have been produced from other parts of the world 
32,33
. A study 





There seems to be little doubt that the malignancies within smaller nodules are at least as common 
as those in larger nodules. However the clinical significance of these small malignancies remains 
controversial. The majority of incidental thyroid cancers are papillary and are relatively benign 
with a 30 yr survival of over 95% 
1
. In fact the very rare (1%) anaplastic carcinoma of the thyroid 
accounts for up to 50% of deaths from the disease 
18
. Thus there is little evidence that looking for 




The question of malignant risk in larger nodules remains unanswered. This is a critical question in 















whether studies looking at predictive accuracy of FNA on small nodules can safely exclude cancer 
in larger nodules particularly since the clinical implications of missing a large thyroid cancer are 
significant. Historically, all nodules over 4cm were subjected to surgical intervention, though a 
literature search does not yield the original work in this area.  
 
In 2009, Madison et al from Wisconson, designed a study to address the diagnostic accuracy of 
FNA in nodules greater than 4cm 
36
. A total of 155 patients were included and all patients had a 
pre-operative FNA and then surgery regardless of the result. The rate of malignancy was 14.8%. 
Correlation between benign cytology and histopathology was poor. There were four false negatives 
for malignancy and 22 benign reports with follicular adenomas diagnosed on final histology. 
While these follicular lesions were not malignant in this series, a follicular neoplasm on cytology 
would usually prompt surgical excision. The overall inaccuracy for cytology was 50%. The 
conclusion of the authors was to support current the norm of excising nodules greater than 4cm 
regardless of FNA findings. As this is only one article, and benign nodules often reach a 
substantial size, it is clearly an area that requires further research.  
 
Section 3: Suspicious Features on Ultrasound  
 
High resolution ultrasound is a critical step in the evaluation of thyroid nodules. Over the last 15 
years, ultrasound features to stratify nodules into low or high malignant risk have been identified 
but the sensitivity and specificity for each feature varies widely from study to study. To get an 
accurate picture of the current information available, each ultrasound risk feature will be evaluated 
separately and, where available, sensitivities and specificities for each suspicious feature is 
extracted from a set of studies analysed in this review.  
 
3.1.Solid/Cystic 
The hypothesis that solid nodules are more likely to be malignant than cystic lesions is confirmed 
in recent ultrasound studies. In fact, many authors looking at newer ultrasound features only 
review solid nodules and exclude cystic lesions altogether 
32,33
. In an older paper from 2001, Koike 
et al from Japan showed that 81.8% of all malignant nodules were completely solid 
37
 and in 2007, 
a Korean study of 1036 patients demonstrated that 98.4% of papillary cancers and 82.6% of 
follicular cancers were solid 
38
. In a large and more detailed study from Boston, it was found that 















became more cystic with 14.3% malignancy in solid lesions, 10.3% in mainly solid lesions, 5.7% 




Thus simple cysts are almost always benign and most malignancies occur in solid or mainly solid 
lesions. However in light of the fact that at least 85% of even solid nodules are benign, more 
sophisticated ultrasound evaluation is necessary.   
 
3.2.Calcification 
Calcification within thyroid nodules is extremely common. There are three patterns of 
calcification: coarse calcification, egg shell calcification and microcalcification 
39
. Coarse 
calcification usually results from dystrophic calcification of necrotic areas in multinodular goitre 
or occasionally solitary nodules 
40
. Peripheral, rim or egg shell calcification surrounds the nodule 
and is usually associated with benign disease. Microcalcifications are less than 2 – 3 mm and 
represent psammoma bodies on histology and are therefore seen primarily in papillary carcinoma 
41
. On ultrasound these have the appearance of small punctate hyperechoic foci.  
 
Studies assessing calcification on ultrasound as a risk for malignancy have focused on micro 
calcifications. Table 2 is a summary of the predictive value of microcalcifications in a series of 
recent studies examined for this literature review: 
 













 1998 Pisa 54.0 76.6 
Kim  
43
 2002 Seoul 59.2 85.8 
Papini  
30
 2002 Rome 29.0 95.0 
Cappelli 
23
 2006 Brescia 72.0 72.0 
Gulcelik 
33
 2008 Ankara 65.4 94.4 
Hong 
32
 2010 Seoul 40.2 85.7 
 
From this table, it appears that while the presence of microcalcifications is generally not a very 


















Many malignancies such as breast and prostate cancer are hypoechoic on ultrasound.  In 2002 Kim 
et al found that while most solid thyroid nodules were hypoechoic compared to the rest of the 
thyroid gland, malignant nodules tended to be markedly hypoechoic. They used the strap muscle 
echogenicity to define marked hypoechogenicity.  In this study, a markedly hypoechoic solid 
lesion was a very specific marker of malignancy. The observation that malignant features in the 
thyroid are remarkably similar to those in the breast is also made: taller rather than wide, 
hypoechoic, irregular margin and microcalcifications. Using any of these criteria to indicate a 
suspicious lesion produced a high sensitivity of 93.8%.  
 
 Table 3 Predictive Value of Hypoechogenicity on Ultrasound 
Author Year Place Sensitivity Specificity 
Rago 
42
 1998 Pisa 66.6 48.6 
Kim 
43
 2002 Seoul 26.5 94.3 
Papini 
30
 2002 Rome 87.1 43.4 
Cappelli 
23
 2006 Brescia 81.0 47.0 
Gulcelik 
33
 2008 Ankara 84.6 61.5 
Hong 
32
 2010 Seoul 39.2 90.9 
 
There is a wide range of sensitivity and specificity for hypoechogenicity as a predictor of 
malignancy. This may in part be due to the fact that there is no uniform definition for 
“hypoechoic”. Some authors use the background thyroid as comparison and others the strap 
muscles. 
  
3.4. Shape Taller than Wide 
It has been hypothesised that nodules that are larger in the anterio-posterier dimension than in the 
transverse dimension (i.e. tall) have a higher risk of being malignant. This may be due to the 
centrifugal growth of the tumour against tissue planes as occurs in the breast 
39
. In one of the 
earliest studies to look at this feature in 2002, Kim et al found it had a low sensitivity (32.7%) but 
high specificity 92.5% for predicting malignancy 
24
. In a more recent study, the sensitivity and 
specificity was reported as 50.5% and 92.4% 
23














ultrasound report this sign hence the data remains scanty and further work is needed before its 
clinical usefulness can be defined.  
3.5. Irregular margin/Absence of Halo 
A nodule is ill defined when more than 50% of its border is not clear on ultrasound 
39
. 
Pathologically this is due to malignant infiltration of surrounding thyroid tissue by carcinoma. 
Benign lesions often have a rim or halo which is a hypoechoic area of compressed thyroid tissue 
surrounding the nodule. This sign is often absent in benign lesions and may be present in some 
malignant lesions. An irregular margin is thus considered to be a better predictor of malignancy 
than the absence of a halo. The sensitivity is variable but generally low with a higher specificity 
(72 – 85%).  
Table 4 Predictive Value of Irregular Margin on Ultrasound 
Author Year Place Sensitivity Specificity 
Papini 
30
2002 Rome 77.5 85 
Kim 
43
2002 Seoul 55.1 83.0 
Cappelli 
23
2006 Brescia 53 81 
Hong 
32
2010 Seoul 58.9 72.2 
3.6. Vascularity 
Three patterns of vascularity in thyroid lesions have been identified: peripheral, intranodular and 
no flow. It is hypothesised that intranodlar flow is associated with malignant lesions and peripheral 
or no flow with benign lesions 
41
. Of all the ultrasound signs for predicting malignancy, vascularity
remains the most contested. Low sensitivities and specificities are reported in most studies and 
many studies do not report on this feature at all. In a number of centres vascularity has only 
recently been part of the routine assessment of thyroid nodules. Sensitivities range from 62 – 74% 
and specificities from 48 – 70% 
23,30,42,44
. In 2010 Moon et al designed a large study to look




Thus for vascularity, there is still lack of consensus that it is a useful sign at all and there is 
















3.7. Features of Benign Lesions 
It is interesting to note that a number of benign features on ultrasound have also been identified 
though not extensively studied. These include: a spongiform appearance, a cyst with a colloid clot, 
“giraffe pattern” created by linear areas of hyper and hypoechogenicity  and diffuse 
hyperechogenicity or “white knight” appearance 
46
. While seeing these features in addition to the 
absence of malignant signs may be reassuring, their predictive value remains untested.  
 
3.8  Summary of Ultrasound Results 
Six ultrasound predictors for malignancy have been presented here. Unfortunately no ultrasound 
sign is both sensitive and specific for the prediction of malignancy. From the evidence reviewed 
here solidity and hypoechogenicity are sensitive signs and microcalcifications, irregular margins 
and taller shape are more specific signs. The presence of any one suspicious ultrasound feature is a 
highly sensitive predictor for a malignant nodule ranging from 83 – 93% 
30,43,45
. This fact may help 
increase the number of nodules for which a benign diagnosis can confidently be assigned.  
 
However a cautionary note regarding follicular carcinoma is raised by Jeh et al 
38
. In their series 
follicular carcinomas had no microcalcifications, often had regular margins and were not 
hypoechoic or tall. These possible differences between the appearance of papillary and follicular 
carcinoma on ultrasound scan still need to be carefully assessed.  
 
The current evidence demonstrates that meticulous ultrasound examination and clear reporting of 
suspicious findings is invaluable in helping clinicians make decisions about FNA and surgery. This 
is an active area of research interest and hopefully more consistent sensitivities and specificities 
will soon be demonstrated.  
 
Section 4: Fine-Needle Apiration Biopsy  
 
Fine-needle aspiration (FNA) biopsy of thyroid nodules is a critical step in distinguishing benign 
from malignant and has improved the surgical yield of diagnostic thyroid surgery from 15 to 50% 
13
. FNA of the thyroid is difficult for a number of reasons. It is a very vascular gland making blood 
only and inadequate sampling common; sampling error can occur because of deep seated lesions or 















complex and requires an experienced pathologist; reporting has been fraught with inconsistency 
and unhelpful terminology and finally some thyroid carcinomas such as follicular and Hurtle cell 




Strategies to improve the predictive value of thyroid FNA includes the creation of a uniform 
classification system, attempts to standardise biopsy technique and the increasing use of ultrasound 
guided FNA (US-FNA). These aspects will be discussed below.  
 
4.1. Universal Classification System - Bethesda Categories 
47
 
The prior lack of standardised reporting for thyroid cytology specimens made communication 
between pathologists, endocrinologists and surgeons difficult. Similar problems had been 
encountered with cervical cytology leading to the Bethesda system for cervical Pap smear results 
in 1988. Inspired by this, the National Cancer Institute hosted a multidisciplinary meeting 
including endocrinologists, pathologists, surgeons and radiologists in Bethesda October 2007. This 
meeting produced the Bethesda System for Reporting Thyroid Cytopathology.  
 




Diagnostic Category Implied Risk 
of Malignancy 
Usual Management 
1. Non diagnostic 
 
 Repeat Bx 
2. Benign 
 
0 – 3 % Observe 
3. Atypia of undetermined significance 
 
5 – 15% Repeat Bx/ Surgery 
4. Follicular Lesion 15 – 30% Diagnostic 
lobectomy 
5. Suspicious for Malignancy 
 
60 – 75% Definitive Surgery 
6. Malignant 
  
















Bethesda Category 1: Non Diagnostic 
An adequate specimen is defined as six groups of follicular cells with at least ten cells per group. 
Specimens are also inadequate if improperly fixed, obscured by blood or too thick. Exceptions to 
the necessary cell count are the presence of abundant colloid with sparse benign follicular cells 
which implies a colloid macrofollicle or abundant macrophages representing a pure cyst. The 
diagnosis of a cyst must be interpreted in the context of ultrasound features. A definitive diagnosis 
such as thyroiditis or clear atypia over rides the cell count criteria and places the specimen in that 
category. This category should not include more than 10% specimens.  
 
Bethesda Category 2: Benign 
An FNA is benign if there are sufficient benign follicular cells with colloid arranged in 
macrofollicles or macrofollicular fragments. Macrofollicles are intact spheres surrounded by flat 
evenly spaced follicular cells. Thyroiditis in the correct clinical context is also considered benign. 
It is estimated that between 60 – 70% of thyroid biopsies should be benign.  
 
Bethesda Category 3: Atypia of Undetermined Significance 
This category was created for lesions which did not fall clearly into the other five categories. It is 
meant to be used sparingly (<7% samples). Samples falling into this category have some features 
of a follicular lesion but in a predominantly benign background. Examples would be predominance 
of microfollicules in an otherwise scanty cellular sample with colloid or Hurtle cells with 
otherwise scanty cells and colloid or a few cells with papillary changes in a background of 
macrofollicles.  
 
Bethesda Category 4: Follicular Neoplasm 
This category is for nodules that may be a follicular carcinoma to be marked for lobectomy. These 
are very cellular smears with minimal colloid. The follicular cells are arranged in a microfollicular 
or trabecular pattern with cellular overlapping. Hurtle cell adenoma/carcinoma are oncocytic 
variants of follicular adenoma/carcinoma characterised by very eosinophilic cytoplasm caused by 
an abundance of mitochondria. The aspirate may be sub categorised as Hurtle cell adenoma if the 
















Bethesda Category 5: Suspicious for Malignancy 
This category is for specimens which have some but not all the diagnostic features for papillary 
carcinomas. It may also include reports suspicious for medullary carcinoma or lymphoma.   
 
Bethesda Category 6: Malignant  
This category is for samples that are conclusive for malignancy, usually 3 – 7 % of samples with 
the majority being papillary carcinoma. The malignant cytological features of papillary carcinoma 
include papillary cellular formations, large nuclei with grooves and prominent nucleoli, cellular 
inclusions resulting in an “Orphan Annie” appearance and calcified psammoma bodies. 
 
4.2. Recommended Technique of FNA 
Technical aspects are important in improving the diagnostic accuracy of thyroid FNA and a 
standardised technique is advisable. A review article from Radiographics Continuing Education 




Pre procedure planning: Informed consent should be taken. There are very few complications 
associated with this procedure and bleeding is exceptionally rare. Routine coagulation checks are 
not necessary but warfarin should be stopped 4 – 7 days prior to the procedure. Stopping aspirin 
remains controversial. Procedure: Patient is a in supine position with the neck slightly extended. A 
22 – 27 gauge needle should be used. Ultrasound guidance is preferable to manual palpation. At 
least two passes into the nodule using either non aspiration or aspiration technique. Non aspiration 
technique relies on capillary action as the needle is passed to and fro in the nodule and rotated on 
its axis. Aspiration may be with a 2 – 10 ml syringe but is not suitable for very vascular lesions. 
Slides should be fixed immediately and the syringe rinsed with saline and sent for cell blocks.   
Post procedure: Simple dressing and local pressure is advised.   
 
 
4.3. Ultrasound guided FNA vs Palpation:  
Ultrasound guided FNA (US-FNA) is gaining popularity over FNA by palpation alone. US-FNA 
makes sense in the context of our awareness that malignancy is as likely to be in a multinodular 
goitre as in a solitary nodule, that many patients with only a solitary nodule on palpation have 
multiple nodules on ultrasound and that impalpable lesions may be large yet difficult to palpate 
due to position in the gland or in patients where the neck is difficult to examine 
49















allows the biopsy of the most suspicious area in complex solid or cystic nodules and ensures that 
the most suspicious nodule in a multinodular goitre is sampled. Ultrasound may also be used to 
avoid vessels in very vascular lesions leading to a higher diagnostic rate.  
 
The hypothesis that US-FNA is superior to FNA by palpation alone is supported by a study from a 
single unit where the inadequate FNA rate decreased from 12.8 – 5.2% after the introduction of 
US-FNA 
50
. A prospective trial from Istanbul compared the accuracy of palpation vs US-FNA and 
found the inadequate rate was 27% vs 13% for the US-FNA group 
51
. The usefulness of US-FNA 
has reached such acceptance that most published trials in the last few years use US-FNA 
exclusively regardless of whether nodules are solitary, multiple, palpable or impalpable.  
 
4.4. Accuracy of FNA  
Use of thyroid FNA has the potential to reduce the number of diagnostic thyroid operations by up 
to 50%, can double the diagnostic rate and reduce cost by 25% 
16
.  Recently published 





However, there is inherent uncertainty in thyroid cytology because of the category of follicular 
neoplasm which triggers surgical excision but cannot reliably predict malignancy. Category 3, 
atypia of unknown significance and Category 1, inadequate cytology add to this uncertainty. The 
high reported overall sensitivity and specificity for FNA is due to the varied definition of 
“positive” and “negative” used in different studies. For example, some studies include Bethesda 
categories 3,4,5 and 6 in their “positive” group as these patients proceed to surgery. The predictive 
value is then calculated but not always defined as whether predictive of malignant or benign 
disease. Other authors exclude the “atypia of unknown significance group” but include “follicular 
neoplasm” as predictive of malignancy. In some cases, it is not stated how overall sensitivities and 
specificities were arrived at.  
 
From a surgical point of view, overall prediction is not as useful as knowing the accuracy of FNA 
for diagnosing benign disease (Bethesda category 2) and malignant disease (Bethesda category 6). 
If we can reliably diagnose benign nodules, these patients can be followed up without surgery. If 
malignant nodules are reliably diagnosed, immediate definitive surgery can be performed. For 
categories atypia, follicular lesions and suspicious for malignancy, diagnostic procedures will still 














With this aim in mind, a number of study results are tabulated below looking at cytology and 
histopathology correlation for the benign and malignant categories and recording the percentage of 
FNA results in the other categories.    
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2587 60 99.7 5 97 13 22 





























2082 88 97.4 4.8 96.6 3.3 6.4 
*”Predictive Accuracy”: where cytology results were benign or malignant, this was the percentage correlation on 
final diagnosis. 
**Percentage not  quoted in this study.   
Correlation between malignant cytology and final malignant histology is very high. These patients 
can thus have definitive surgery. The final diagnosis of a benign lesion is based on clinical and 
ultrasound follow up of varying lengths of time. Patients with increasing nodule size were either re 















The lack of final histology in the benign category makes true assessment of the accuracy of FNA 
difficult. At least one study, Yassa et al 
31
followed patients up for nine years and still found a very 
low rate of malignancy in nodules classified benign on initial FNA. It therefore seems a reasonable 
clinical strategy to watch these patients if ultrasound, FNA and clinical assessment are all in 
keeping with benign disease.  
 
The correct management of patients with an inadequate FNA (5 – 20%) remains controversial. 
Many authors suggest diagnostic surgery as between 25 – 38% of second biopsies will remain 
inadequate and 24.5% of these nodules may be malignant 
53
. Others point out that inadequate 
cytology is more common in cystic or mainly cystic nodules where the risk of cancer is lower and 
therefore suggest follow up ultrasound if no there are no other suspicious features 
54
. The decision 
to re biopsy, observe or operate is currently up to the discretion of the treating clinician.  
 
4.5. Overall Preoperative Diagnostic Accuracy 
If recent FNA accuracy rates reported at high volume centres can be reproduced elsewhere, 60% 
patients should have a confident diagnosis of benign disease and 5% a diagnosis of malignancy. 
This leaves uncertainty for 35% who still need diagnostic surgery and 40 – 50% of these excisions 
should be positive for malignancy.  
 
Of the literature reviewed, only one large study from Harvard, Boston was close to this with 56% 
malignant rate for diagnostic surgery 
31
. Other centres show an upward trend but still lower 
percentages:  Maia et al in 2011 25% 
55
, Tan et al 28% 
56
, Gul et al 2009 32.7% 
27
 and Cheung et al 
2007 33% 
57
. This is unsurprising as results from research in large volume centres are often 
difficult to match in local environments with unique clinical pressures and skills levels.  
 
Section 5: Research Questions and Conclusion 
 
A number of questions remain unanswered in the field of thyroid nodules.  
 It is heartening to read that up to 60% thyroid nodules should have a benign diagnosis on 
FNA. However, this is usually not confirmed on histology. To confidently use this 
information in the clinical arena and simply follow these patients up, research looking at 















 The large thyroid nodule and its management has recently received very little attention with 
a massive focus rather on impalpable and sub centimetre nodules. As differentiating benign 
from malignant in this context is unequivocally clinically relevant, more work is needed in 
this area.  
 The answer to the question of how intensively to investigate sub centimetre nodules can 
only be answered once the clinical outcomes of micro carcinomas have been clarified. As 
the numbers of these small cancers increase, long term studies should shed some light onto 
whether or not we should be investigating small thyroid lesions at all. 
 Lastly some promising work is being done on molecular, hormonal and biochemical 
markers to help predict malignancy and distinguish more aggressive cancers from those 
with a more indolent course. As these are perfected, they may add another arm to the 















Part C: Research Article as for submission to the 
South African Journal of Surgery 
Pre-Operative Diagnosis of Thyroid Cancer: 
Clinical, Radiological and Pathological Correlation 
Abstract 
Aim:
The aim of this study was to assess the accuracy of the diagnosis of thyroid cancer in our
institution. 
Methods:
Data for all patients diagnosed with thyroid carcinoma from 2004 -2010 at Groote Schuur
Hospital was retrospectively collected. The patients were identified from the oncology, pathology
and surgical records and a standardised confidential proforma was used to capture the
information. The pre-operative clinical assessment, ultrasound and fine needle biopsy results were
analysed and compared to the final histopathogy results and the total number of diagnostic
lobectomies were recorded 
Results:
A total of 109 patients, 79 female and 30 male patients were identified. The majority, 99, were well
differentiated thyroid cancers: 56 papillary 30 follicular, 10 mixed and 3 Hurtle cell carcinomas.
There were 6 anaplastic and 4 medullary carcinomas. 38 patients had a definitive pre-operative
diagnosis, 61 a suspicion of malignancy and 10 had surgery for benign disease. Fine needle
aspiration biopsy (FNA) was inadequate in 11 patients, benign in 47, suspicious in 13 and
malignant in 38 patients diagnosed with thyroid carcinoma. FNA diagnosed all patients with 
medullary and anaplastic carcinoma but less than half of patients with well differentiated thyroid
carcinoma. Ultrasound detected at least one suspicious feature in 44 patients. Microcalcification 
was the most common sign. 229 diagnostic lobectomies were performed from 2004 – 2010 of
which 56 had thyroid cancer and 46 required completion lobectomies. The overall diagnostic rate
for malignancy was 24.4%. 
Conclusion:
The diagnosis of well differentiated thyroid carcinoma is difficult and requires accurate pre-
operative ultrasound and cytopathology. Recent advances in thyroid diagnostics using high 
















The diagnosis or exclusion of thyroid cancer in the thyroid nodule remains a clinical dilemma for 
general surgeons and endocrinologists. The general prevalence of thyroid nodules is astounding. 
Thyroid nodules are detectable in 5% of the normal population on clinical examination 
11,12
, in
over 48% on high resolution ultrasound 
14
 and over 50% at autopsy 
15
. The widespread use of
imaging in modern medicine is resulting in a flood of incidental thyroid nodules, many of them 
impalpable and asymptomatic.  
In sharp contrast, thyroid cancer remains a rare disease with an incidence of only 1-2/100 000 of 
the population 
13
. Papillary carcinoma and follicular carcinoma remain the most common 
histological subtypes and, in general, have very good long term prognosis and survival 
1
. Poor
prognosis and decreased survival in thyroid cancer is associated with the rare and aggressive 
anaplastic and medullary histological subtypes 
18
which are relatively easy to diagnose pre
operatively.  
As nodular disease of the thyroid is very common, cancer rare and the diagnosis difficult to 
confirm, clinical decision making is difficult. Yet having a confident pre-operative diagnosis of
thyroid cancer greatly facilitates appropriate surgical intervention, decreases unnecessary surgery,
and is safer for patients. Recent advances in the use of ultrasound and fine needle aspiration biopsy
have resulted in improved pre-ope ative diagnosis of nodules in many centres. These advances 
include defining ultrasound features that predict malignancy, increased use of ultrasound guided
fine needle aspiration biopsy (US-FNA), as well as standardised reporting of cytopathological
specimens. 
Aim: 
The aim of this study was to assess the pre-operative accuracy of the diagnosis of thyroid cancer in 
our institution, evaluate the extent to which ultrasound and fine needle aspiration biopsy (FNA) 
was utilised and to identifying the potential areas for improvement. Comparing this to the most 
recent international experience will assist in streamlining our diagnostic algorithm and surgical 


















A retrospective collection of data was conducted for all patients diagnosed with thyroid carcinoma 
from 2004 -2010 from a single institution. The patients were identified from the oncology, 
pathology and surgical records. In addition, all patients who had undergone a diagnostic lobectomy 
during this time period for features suspicious for thyroid carcinoma were identified. The pre-
operative clinical assessment, ultrasound and fine needle biopsy results were compared to the final 
histology results. A standardised confidential proforma was used to capture the data from patients 
with confirmed thyroid carcinoma. The total number of diagnostic lobectomies for suspicious 
nodules during this time period was recorded separately as a simple total and compared to the final 
positive malignancy rate.  
 
Ultrasound results were recorded as suspicious if any feature known to be predictive of 
malignancy was reported. This included: microcalcifications, hypoechoic echogenicity and 
increased vascularity. Irregular margin and shape were not recorded in any ultrasound results. Fine 
needle biopsy reports were recorded as benign if colloid, macrophages and follicular cells were 
reported, suspicious if any suspicious cytological features were reported and malignant if a 
definitive diagnosis was given. The final assessment of the thyroid nodule pre-operatively as 
documented by the surgical team was recorded as malignant, suspicious multinodular goitre 
/solitary nodule or benign. Patients with malignancies diagnosed on lobectomy underwent a 
















A total of 109 patients, 79 female and 30 male patients were diagnosed with thyroid cancer on 
final histopathology reports. The majority, 99 were well differentiated thyroid cancers with 56 
papillary carcinoma, 30 follicular carcinoma, 10 mixed follicular/papillary and 3 Hurtle cell 
carcinomas. There were 6 anaplastic and 4 medullary thyroid carcinomas. The majority, 65%, of 
patients had solitary nodules. 
General Risk Factors 
Most patients did not have any warning signs on history or physical examination. Only one had 
been exposed to radiation, two had a family history of MENII, 12 were under 25 and one patient 
had a family history of papillary carcinoma. Most patients were asymptomatic with only 14
presenting with symptoms of compression due to multinodular goitre, and 4 complained of
significant voice changes. 14 patients had either metastatic disease or clinically detectable
lymphadenopathy at presentation. 
Definitive Diagnosis of Malignancy (38 patients) 
In 38 patients there was a definitive pre-operative diagnosis of thyroid cancer. This included all 10
of the patients with anaplastic and medullary cancers, 22/56 papillary cancers and 6/30 follicular
cancers. In the 22/56 patients with definitive papillary cytology results, nine were obtained from 
biopsy of metastatic cervical lymph nodes. All 6/30 patients with follicular carcinoma were
diagnosed pre operatively on biopsy of metastases (2 lung, 3 bone and 1 lymph node.)
Suspicious for Malignancy (61 patients) 
61 patients were operated on for the suspicion of malignancy, 39 solitary nodules and 22 
suspicious nodules in a multinodular goitre. Of these 46 underwent a diagnostic lobectomy 
followed by a completion thyroidectomy at a later date. In 8 patients, the initial lobectomy was 
adequate surgical management, 5 patients had a primary total thyroidectomy and 2 had on table 
frozen section of the lobe and immediate total thyroidectomy.  
Benign Diagnosis (10 patients) 
In 10 patients the diagnosis of thyroid cancer was unexpected. Their indication for surgery was 
multinodular goitre with compression or thyrotoxicosis. In 50% of these patients lobectomy was 














was performed on 3 patients and 2 required completion thyroidectomy. Table 1 summarises these 
findings by histological sub type.  








Papillary 22/56 Follicular 6/30 Mixed/Hurtle
0/13
Anaplastic 6/6 Medullary 4/4
Total No.
Dxn Pre op
Accuracy of Fine Needle Aspiration Biopsy (FNA)
All patients had fine needle biopsy performed pre operatively. Of the 109 patients, 58 had a
cytology report which did not assist in the pre-operative diagnosis: 11 biopsies were inadequate 
and 47 consistent with a benign lesion. In 51 patients, the FNA was helpful. All anaplastic and
medullary cancers were diagnosed confidently on FNA. In papillary cancer, 13 patients were
positively diagnosed with FNA of the thyroid gland and the remaining 9 from lymph node
biopsies. A further 6 results were suspicious. For follicular carcinoma, the only cancers diagnosed 
on FNA were from metastasis and 3 FNA from the thyroid were reported as suspicious. The


























































Accuracy of Ulltrasound  
Ultrasound reports mentioned at least one malignant feature in 44 patients (40.3%). The presence 
of micro calcifications was the most commonly reported suspicious feature on ultrasound. Where 




During the seven year period, a total of 229 diagnostic lobectomies for the suspicion of cancer 
were performed. There was a significant rise in the annual number of diagnostic lobectomies from 
2004 to 2010 (13, 25, 27, 19, 36, 55, and 54). The overall diagnostic rate for malignancy was 
24.4% (56 patients). In 8 patients, lobectomy was adequate surgical management but 46 patients 
required further surgery and completion thyroidectomy. Figure 2 summarises the surgical 














Figure 2: Diagnostic Surgical Interventions Groote Schuur Hospital 2004 - 2010 
Discussion 
The results of this study illustrate the difficulty of diagnosing well differentiated thyroid cancer.
The lack of a single sensitive and specific pre-operative diagnostic tool results in a large number of
diagnostic lobectomies. The general demographics of our group with women predominating, two 
thirds being solitary nodules and well differentiated cancer representing over 90% of malignancies,
is consistent with the international experience
1
. 
High resolution ultrasound is critical in the diagnosis of thyroid lesions. A number of ultrasound 
features have been identified over the last 10 – 15 years which assist in predicting the risk of 
malignancy in a nodule. These include: solid vs cystic consistency, echogenicity, 
microcalcifications, shape, irregular margin and central/nodular vascularity 
39.
 There is a wide
range of sensitivities and specificities reported for each sign and intense research in this area is 
ongoing. The overall sensitivity reported for any one suspicious ultrasound feature is 83 – 93% 
30,43,45
. 
In our series, there was a lack of consistency in the quality of ultrasound reporting. This may be 
the result of the large number of consultants and trainees performing ultrasounds and the lack of a 






























shape and irregular margin were never reported. The reporting of other signs was variable and in 
only 40.4% of nodules which proved to be malignant, was a suspicious sign reported. The 
commonest suspicious feature reported was micro calcifications. The absence of suspicious 
features as an important negative was not specifically stated in reports.  
Ultrasound reports of multinodular goitres usually reported on dominant nodules implying the 
largest nodule. However recent research suggests that size is not a factor in predicting malignancy 
31,32,33
and thus the most ultra-sonographically suspicious nodule and not the largest should be 
identified for biopsy. In the work done by Papini
30
, the efficiency of using malignant ultrasound
features to target biopsy in multinodular goitres resulted in the diagnosis of 21.7% of malignant 
nodules as opposed to only 5.8% when using size alone. The FNA of the largest nodule in a 
multinodular goitre would have represented a sampling error and contributed to the high benign 
false negative cytology results in this series.   
According to international guidelines, FNA has improved the yield rate of malignancy from
diagnostic thyroid surgery from 15% to 50%
13
resulting in a significant reduction of unnecessary
operations. FNA accuracy is reported to range between is 80 – 90%
13
though the methodology for
generating these predictive values vary from series to series. False negative benign results are
reported to be between 1-3% in a number of research studies 
21,22,25,31
. In contrast to these high
accuracy rates, FNA results in our series were unhelpful in 53% of patients. While cytology was
100% accurate in diagnosing anaplastic and medullary carcinoma, the performance for well 
differentiated cancers was poor. 
In patients with well differentiated cancers on histology, the pre-operative cytology was reported 
as benign in for 43%. There was greater accuracy in diagnosing papillary carcinoma where 
cytology was positive or suspicious in 53% of patients. For follicular carcinoma, the FNA was 
only suggestive in 33% of patients. Although follicular carcinoma is impossible to diagnose on 
cytology, a report of a follicular neoplasm (Bethesda category 4) 
47
 with features of microfollicules
and no colloid was only reported in a small group of patients. This would be regarded as a positive 
cytology result and prompt surgical excision of the lesion.  
Multiple factors contributed to the low diagnostic yield of fine needle aspiration biopsy. Sampling 
error probably played a major role. Contrary to the practice in many high volume centres, 















a particular nodule in a multinodular goitre is reported as suspicious.  However US-FNA is often 
not done by the same radiologist who initially diagnosed the lesion. Hence often the largest or 
dominant and not the most ultrasonographically suspicious nodule was biopsied. Patients felt to 
have solitary nodules were biopsied on palpation alone which may also have resulted in sampling 
error, particularly in complex solid-cystic nodules. In addition, there was no standardised 
technique for thyroid FNA across radiology and surgical services.  
 
The reporting of cytopathology added another area of potential inaccuracy. The study period 
begins before the international Bethesda guidelines on reporting thyroid cytopathology were 
published 
47
. However even cytopathology done after 2007 was not routinely reported according to 
the Bethesda category guidelines. Thus interpretation by treating surgeons remained difficult. 
Many centres have only a few dedicated cytopathologists who have a special interest in this area 
looking at thyroid cytoloty. The consultant staff to support this practice within our pathology 
department may not have allowed for this degree of sub-specialisation and partly resulted in the 
variable reporting of thyroid cytology.  
 
Surgery for thyroid carcinoma or suspicion of carcinoma increased steeply over the seven year 
period of the study from only 13 diagnostic lobectomies in 2004 to 54 in 2010. This is probably 
due to changes in unit practice as well as increased referrals of incidental thyroid nodules. Our 
overall rate of cancer of 24.4% for diagnostic procedures is not completely out of keeping with 
units of similar size 
55, 56
. However in large centres where there is a focus on thyroid nodular 
disease, 56% of all diagnostic surgery is positive for malignancy 
31
. While some uncertainty is 
inevitable with thyroid cytology, the correct application of Bethesda criteria should result in a 
benign diagnosis in approximately 60% of nodules and a confident malignant diagnosis in at least 




In this series, of the 229 patients who underwent a diagnostic lobectomy, only 56 had thyroid 
cancer and 46 required completion surgery. Thus theoretically 219 patients had an avoidable 
operation. If the correct use and interpretation of high resolution ultrasound and FNA can produce 
a cancer yield for diagnostic surgery of 50%, this number could theoretically have been reduced to 
114. Clearly the translation of research results from high volume centres to a local context should 

















The results of this study illustrate the complexity of thyroid nodule assessment specifically with 
regards to the diagnosis of well differentiated thyroid cancer. It also highlights the need for 
multidisciplinary co-ordination as thyroid nodular disease is a clinical problem which cuts across 
several disciplines including endocrinology, pathology, radiology and surgery. While the 
diagnostic accuracy for ultrasound and FNA was relatively low in this study, the overall diagnostic 
surgical yield was comparable to that in other smaller centres.  
The reported results of preoperative diagnostic techniques from the international literature are a
source of optimism for surgeons looking for rational, safe and efficient strategies to manage
thyroid nodules. Achieving similar clinical outcomes locally will mean translating research results 
from high volume centres with experienced, committed multidisciplinary teams, to the practical 
reality of our pressurised clinical context. This requires both local research and protocols which
include the standardisation of ultrasound reporting, implementation of Bethesda Category
Classification for cytology results and improvements in biopsy techniques. Engagement with
radiology, endocrine and pathology colleagues is thus critical if we are to rationalise our collective
management of the ubiquitous thyroid nodule. This is a long term and energy intensive project but
holds the promise of reducing the number of unnecessary operations done and allowing greater 
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Appendix 3: Standardised Proforma 
 
Thyroid Cancer Data Sheet 
 
 
Personal Details  
 
Patient name ………………………… Folder Number …………….. 
 








Symptoms:     Risk Factors  
 
1. Incidental    1. Age<25 
2. Airway   2. Radiation 
3. Dysphagia    3. Family History 
4. Systemic/LOW   4. MEN 






Signs:      Special Investigations 
 
1. Solitary Nodule   1. Euthyroid/Not 
2. MNG     2. Ultrasound 
3. Lymphadenopathy   3. Nuclear Medicine  
4. Metastases    4. Cytology 
5. RLN paresis    5. CT 















Ultrasound Report:     Cytology: 
 
1. MNG      1. Inadequate 
2. Dom nod MNG (Susp)   2. Colloid/macrophages 
3. Solitary Nodule (Not susp)   . Follicular cells/colloid 
4. Solitary Nodule (Susp)   4. Atypical foll. cells/pap 




Pre Operative Diagnosis:    Operation: 
 
1. MNG      1. Lobectomy only 
2. Suspicisous SN/MNG    2. Total thyroidectomy 
3. Definitive ca     3. Lobectomy + completion 
4. Lymphadenectomy (central/lateral) 
 




Complications:     Adjuvant Treatment 
 
1. Re-op bleeding    1. I131 
2. RLN injury     2. Other ……… 
3. Hypoparathyroidism    3. None 





Final Histology:     Outcome: 
 
1. Papillary ca      1. Well 
2. Follicular ca     2. Alive with recur/disease 
3. Mixed      3. Demised 
4. Hurtle cell     4. Lost to follow up 
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observations or research of relevance to clinical medicine. References should preferably be limited 
to no more than 15. 
 
Short reports or scientific letters, which include case reports, side effects of drugs and brief or 
negative research findings should be 1000 words or less, with 1 table or illustration and no more 
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